BCM
NRXPW

Basso Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Basso Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,000
Closed -$4K – 187
2018
Q2 		$4K Hold
10,000
– – ﹤0.01% 191
2018
Q1 		$5K Hold
10,000
– – ﹤0.01% 178
2017
Q4 		$4K Buy
+10,000
New +$3.81K ﹤0.01% 172

Other funds holding NRXPW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Basso Capital Management's NRXPW Position: Q3 2018 in Review

Basso Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q3 2018, closing a stake of 10,000 shares — an estimated $4K sold.

Basso Capital Management first reported a position in NRXPW in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q1 2018. 15 funds tracked by Wall St. Rank hold NRXPW as of Q3 2018.

  • Basso Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q3 2018 after selling out during the quarter.
  • Basso Capital Management sold 10,000 NRX Pharmaceuticals Warrant shares in Q3 2018, an estimated $4K.
  • Basso Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 3 quarters.
  • Basso Capital Management's NRX Pharmaceuticals Warrant position peaked at $5K in Q1 2018.
  • 15 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q3 2018.

Based on Basso Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.